A dose escalation study in sheep of the effects of the benzodiazepine CNS 7056 on sedation, the EEG and the respiratory and cardiovascular systems
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background and purpose: CNS 7056 is a new, rapidly metabolized benzodiazepine. The effects of escalating doses of CNS 7056 on sedation, and respiratory and cardiovascular function, were examined in conscious, chronically instrumented sheep for the first time. Experimental approach: Three sheep were given doses of CNS 7056 (0, 0.037, 0.074, 0.18, 0.37, 0.74, 2.21, 4.41 and 8.82 mg kg−1) as 2 min intravenous infusions in order on consecutive days. A range of physiological variables, including the EEG, were measured. Key results: Sheep became transiently drowsy for the lowest (0.037 and 0.074 mg kg−1) doses of CNS 7056, whereas the highest (8.82 mg kg−1) dose produced profound loss of consciousness (LOC) for over 30 min. The EEG alpha power correlated well (r=0.91) with duration of LOC and had a high signal‐to‐noise ratio. CNS 7056 reduced respiratory rate (maximum 33%) and dose‐dependently increased arterial carbon dioxide tension (maximum 12%). There was a transient, dose‐related reduction in arterial oxygen tension (maximum 34%), but haemoglobin desaturation was minimal (maximum 4%). CNS 7056 produced a dose‐related transient drop in mean arterial blood pressure (maximum 12%) but cardiac output was unchanged. Conclusions and implications: Doses of 0.37–2.21 mg kg−1 of CNS 7056 produced sedation for 9–25 min without excessive respiratory or cardiovascular depression, and would be suitable for pharmacokinetic studies. The power in the alpha band of the EEG can be used as a continuous measure of the sedative effects of CNS 7056. British Journal of Pharmacology (2008) 155, 52–61; doi:10.1038/bjp.2008.228; published online 16 June 2008
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guide to receptors and channels (GRAC), 5th edition
Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947
Kilpatrick (2007) · doi:10.1097/01.anes.0000267503.85085.c0 · Cited by 381
Cited by
Antonik, L. J., Goldwater, D. R., Kilpatrick, G. J., Tilbrook, G. S., & Borkett, K. M. (2012) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31823f0c28 · Cited by 374
Remimazolam: non-clinical and clinical profile of a new sedative/anesthetic agent
Kilpatrick, G. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.690875 · Cited by 262
Remimazolam besilate, a benzodiazepine, has been approved for general anesthesia!!
Masui, K. (2020) · Journal of Anesthesia · doi:10.1007/s00540-020-02755-1 · Cited by 123
Induction and maintenance of procedural sedation in adults: focus on remimazolam injection
Chen, W., Chen, S., & Huang, Y. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1901575 · Cited by 25
“It has been more than 10 years since the initial investigations of remimazolam were conducted in animals [8,110].”
Background
Metadata
- Authors
- Upton, R. N., Martinez, A. M., & Grant, C.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2008-09
- Volume
- 155
- Issue
- 1
- Pages
- 52-61
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2079200443
- Cited by
- 56
- References
- 2
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A dose escalation study in sheep of the effects of the benzodiazepine CNS 7056 on sedation, the EEG and the respiratory and cardiovascular systems. https://app.cochat.ai/papers/10.1038/bjp.2008.228
- The paper
- Upton, R. N., Martinez, A. M., & Grant, C. (2008). A dose escalation study in sheep of the effects of the benzodiazepine CNS 7056 on sedation, the EEG and the respiratory and cardiovascular systems. British Journal of Pharmacology. https://doi.org/10.1038/bjp.2008.228
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.